The company is taking all precautions, safety and social distancing measures and implementing all applicable guidelines issued by the authorities across its operations and offices for prevention and containment of COVID-19, a BSE filing added.
GE Power India on Saturday said it has resumed production at its Durgapur plant in West Bengal. The company had suspended operations temporarily at its facilities located at Durgapur, West Bengal, and Noida, Uttar Pradesh, due to the lockdown imposed by the government in March to contain COVID-19 pandemic.
"We would like to inform that, from today i.e. 02 May 2020, after obtaining requisite approvals/permissions from the competent authority/ies the Company has resumed its manufacturing operations at its Durgapur factory, to the extent permitted by the local administration/competent authority," a BSE filing said.
The company is taking all precautions, safety and social distancing measures and implementing all applicable guidelines issued by the authorities across its operations and offices for prevention and containment of COVID-19, it added.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
"We will continue to follow the recommendations/advisories as may be issued from time to time by the relevant authorities," it said.Follow our full coverage of the coronavirus pandemic here.